As we approach the 2024-25 respiratory virus season in the Northern Hemisphere, health experts have started to outline what we can expect. According to a recent report from the CDC, there is an 80% chance that the peak hospitalization rates from COVID-19, influenza, and respiratory syncytial virus (RSV) will be similar to or lower than those seen during last year’s virus season. While this is encouraging news, there are still factors that could lead to a more severe virus season.
The CDC’s August 29 report highlights three crucial factors that could significantly impact the burden of hospitalizations this season:
- The Emergence of a New COVID-19 Variant – While previous infections and vaccinations have built a layer of immunity across populations, there is still the potential for a new COVID-19 variant to emerge that could evade this immunity. Such a variant could result in more severe illness and higher hospitalization rates. As history has shown, new variants of viruses can significantly alter the trajectory of infection rates, potentially overwhelming healthcare systems.
- Predominance of a Severe Influenza Subtype – The CDC also warns that if a particularly severe influenza subtype becomes predominant, it could lead to higher rates of severe illness and hospitalization. Influenza strains differ in their severity, and some are more likely to cause complications, particularly in vulnerable populations such as the elderly and those with preexisting conditions. Close monitoring of flu activity is essential to gauge how the season will unfold.
- Low Vaccine Uptake or Effectiveness – Another key factor influencing the burden of the upcoming season is the uptake and effectiveness of vaccines. Historically, vaccine hesitancy has been a challenge, and this year is no exception. As of May 2024, only 22.5% of adults in the US had received last year’s updated COVID-19 vaccine. Low vaccination rates, combined with the potential for decreased vaccine effectiveness, could lead to increased hospitalizations. The effectiveness of both the COVID-19 and flu vaccines against severe outcomes, including hospitalizations, will be closely watched throughout the season.
In addition to these three factors, there are also concerns about public health threats from avian influenza outbreaks among livestock. Although there is no current evidence of human-to-human transmission, experts are urging more testing to ensure that outbreaks are detected early.
Why Monitoring Your Body Temperature Is Crucial This Season
Given these potential risks, staying vigilant about your health is more important than ever. One simple yet crucial practice is regularly monitoring your body temperature. A fever is often the first indication of a viral infection, and early detection can make a significant difference in managing the spread of these viruses.
During virus season, checking your body temperature twice a day can help you catch early signs of illness, even before other symptoms arise. Having an easy-to-use, reliable, and accurate thermometer, such as the Exergen Temporal Artery Thermometer, can be a game-changer in this regard. This device is designed for simple, non-invasive use, making it perfect for daily checks. By providing quick and accurate readings, it ensures that you can respond promptly if your body temperature rises.
As we enter another virus season, awareness and proactive health measures are essential. With factors such as the emergence of new variants, severe influenza subtypes, and low vaccine uptake potentially influencing the severity of the season, staying prepared is crucial. One effective way to do so is by regularly checking your body temperature, allowing for early detection of illness and quicker response. Investing in a reliable thermometer like the Exergen Temporal Artery Thermometer can help you stay on top of your health and safeguard those around you during this critical time.
Source:
EXERGEN P/N 850236, Rev 1